About US
Contact us
-
Challenges for Innovators in the US Pharmaceutical MarketProfitable and continuous participation in the US pharmaceutical market is fraught with challenges. The barriers to entry are considerable and sustained growth is always in question. Innovators oper2014/11/28
-
Japan grants orphan drug designation for Alexion’s Soliris to treat NMOUS-based Alexion Pharmaceuticals has obtained orphan drug designation (ODD) from Japan's Ministry of Health, Labour and Welfare (MHLW) for its Soliris (eculizumab) for the treatment of neuromyelitis o2014/11/28
-
GSK receives US FTC approval to acquire Novartis’ vaccines businessBritish drug-maker GlaxoSmithKline (GSK) has received approval from the US Federal Trade Commission (FTC) for its proposed acquisition of Novartis' vaccines business. The acquisition excludes influen2014/11/28
-
Janssen seeks FDA approval for Yondelis drug to treat advanced STSJanssen Research & Development is seeking approval from US Food and Drug Administration (FDA) for its Yondelis (trabectedin) to treat patients with advanced soft tissue sarcoma (STS). A new drug2014/11/27
-
Eisai opens new packaging facility for thyroid cancer treatment in UKJapan-based Eisai has opened a new global potent packaging facility for its investigational compound, lenvatinib, at the EMEA Knowledge Centre (EKC) in Hatfield, UK. The new facility will handle the2014/11/27
-
Automation of Process Control within the Pharmaceutical IndustryWhile most pharmaceutical businesses have adopted process automation in one format or another, the technology has evolved considerably over the past few years, leading to improvements in design, effic2014/11/27
-
Merck and NewLink Genetics partner to develop Ebola vaccine candidateUS-based pharmaceutical company Merck has signed an exclusive worldwide license agreement with NewLink Genetics to develop the latter's Ebola vaccine candidate. Both firms will carry out research, as2014/11/26
-
AbbVie buys active pharmaceutical ingredient (API) facility in SingaporeUS-based AbbVie has acquired a small molecule active pharmaceutical ingredient (API) manufacturing site in Tuas Biomedical Park, Singapore. AbbVie intends to expand global operations of small molecul2014/11/26
-
European Commission grants approval for Novartis's Signifor to treat acromegalySwiss drug-maker Novartis has received approval from European Commission for its Signifor (pasireotide) intramuscular injection to treat adult patients suffering from acromegaly. The approval was gra2014/11/26
-
New Whitepaper Explores How Malvern Instruments Extends a QbD Approach to Instrument Design'Extending the boundaries of QbD', a new whitepaper explores the application of Quality by Design (QbD) principles to the development of analytical instrumentation and its benefits. Through the examp2014/11/25